Law360 (February 1, 2018, 6:15 PM EST) — Jones Day secured a record $2.5 billion patent infringement jury award for Idenix Pharmaceuticals LLC and argued before the U.S. Supreme Court that the Patent Trial and Appeal Board can’t choose which challenged patent claims it may review, earning the …
